Fine Foods & Pharmaceuticals N.t.m. Spa · MIL:FF
Fine Foods & Pharmaceuticals N.t.m. Spa — 9M 2024 Earnings Presentation
38 slides from Fine Foods & Pharmaceuticals N.t.m. Spa's earnings presentation, Nov 14, 2024
Slide 1: 9M 2024 Results Presentation
9M 2024 RESULTS PRESENTATION 14/11/24
Slide 2: Index
FINE FOODS 9M 2024 INDEX 2 RESULTS PRESENTATION 3 1 2 Index WE CREATE FINANCIALS SHAREHOLDING VALUE STRUCTURE 4 5 INVESTOR BACK UP INFORMATION ESG DETAILS & CONTACTS
Slide 3: We Create Value
FINE FOODS 9M 2024 3 RESULTS PRESENTATION WE CREATE VALUE
Slide 4: Fine Foods at a glance
FINE FOODS 9M 2024 WE CREATE VALUE 4 RESULTS PRESENTATION Fine Foods Italian independent CDMO active in Strong partnership with at a glance the pharmaceutical, nutraceutical multinational clients in all our and cosmetics industries through reference markets three Business Units Stable presence of Ei
Slide 5: Strong corporate culture
FINE FOODS 9M 2024 WE CREATE VALUE 5 RESULTS PRESENTATION Strong corporate culture Three different integrated and cross-functional business units committed to Fine Foods’ key business principles
Slide 6: European reference markets
FINE FOODS 9M 2024 WE CREATE VALUE 6 RESULTS PRESENTATION European CAGR PHARMA1 (€BN) 5.0% PHARMA2 – CDMO reference 9.8% 18% 23% Italy markets 644.7 784.7 5% Market Germany France 442.8 6% value: United Kingdom 13.5 €BN Spain 20% 12% Greece Others 16% 2019a 2023e 2027e FOOD – DIETARY SUPPLEMENT3 (€B
Slide 7: Consistently outperforming reference markets
FINE FOODS 9M 2024 WE CREATE VALUE 7 RESULTS PRESENTATION Consistently Reference markets show high steady growth and resilience during recessions Fine Foods has substantially outgrown its reference end-markets in the last decade, with outperforming 2023 sales at 2.9X the 2013 level reference Europea
Slide 8: Selection of products
FINE FOODS 9M 2024 WE CREATE VALUE 8 RESULTS PRESENTATION Selection of products • Nutraceuticals (Nutra BU) • Pharmaceuticals (Pharma BU) • Cosmetics (Cosmetic BU)
Slide 9: What we do
FINE FOODS 9M 2024 WE CREATE VALUE 9 RESULTS PRESENTATION NUTRA PHARMA COSMETIC What we do PHARMACEUTICAL FORMS Capsules Tablets Powders Granules Liquids Creams Gels Toothpaste Parfum Cross-fertilised innovation & Lotions is implemented by exploiting our expertise in different fields, best practices
Slide 10: Flexible and integrated business model
FINE FOODS 9M 2024 WE CREATE VALUE 10 RESULTS PRESENTATION Flexible NUTRACEUTICALS AND COSMETICS and integrated Concept Development Regulatory Compliance Formulation Production Distribution business model Fine Foods is positioned within the value creation chain of pharmaceuticals, PHARMACEUTICALS nu
Slide 11: Customers' loyalty
FINE FOODS 9M 2024 WE CREATE VALUE 11 RESULTS PRESENTATION 2020 Customers’ 2010 loyalty 2000 Retained key clients acquired before 2000 with several new ones added afterwards, including those derived from our recent acquisitions in the cosmetic industry. Note: Sigma-Tau & Alfa Wassermann (now Alfasig
Slide 12: Strong holistic ESG
FINE FOODS 9M 2024 WE CREATE VALUE 12 RESULTS PRESENTATION 2010 2013 2015 2019 2022 Strong Organisation, management and • Sustainability report • Impact report (Benefit Corporation) holistic control systems • Diversity and Inclusion program under Legislative Standard which Standard describing Decree
Slide 13: R&D for efficient and high-quality product development
FINE FOODS 9M 2024 WE CREATE VALUE 13 RESULTS PRESENTATION R&D for OPPORTUNITY LAB efficient and Formulae databank ➝ Wide range of ready-to-use high-quality product formulations product development INNOVATION LAB Innovative products ➝ A lab to offer out-of-the-box ideas 136 employees NUTRACEUTICALS
Slide 14: Three production plants located in a European cluster of excellence
FINE FOODS 9M 2024 WE CREATE VALUE 14 RESULTS PRESENTATION BREMBATE Three production LOMBARDIA plants located in a European 1 BERGAMO cluster of 2 ZINGONIA Excellence MILANO 3 TRENZANO Italy and Lombardia, where our plants are located, are a cluster of excellence for our sectors. This has a positive
Slide 15: Financials
FINE FOODS 9M 2024 15 RESULTS PRESENTATION FINANCIALS
Slide 16: 9M 2024 consolidated revenue
FINE FOODS 9M 2024 FINANCIALS 16 RESULTS PRESENTATION (4.6%) 185.7 177.2 9M 2024 (€M) consolidated revenue 9M 2024 Consolidated Revenue showed a slight decrease compared to the excellent 9M 2023 performance 9M 2023 9M 2024 9M 2024 Revenue highlighted the REVENUE BREAK-DOWN continuous growth trend in
Slide 17: 9M 2024 EBITDA
FINE FOODS 9M 2024 FINANCIALS 17 RESULTS PRESENTATION +26.0% REVENUE % 9M 2024 REPORTED EBITDA (€M) 23.1 EBITDA 18.3 Overall, an impressive improvement of 26.0% in 9M 2024 EBITDA and 27.8% in ADJ EBITDA 9M 2024 EBITDA Margin confirmed at 13.0% improved by >300 bps 9M 2023 9M 2024 9M 2024 EBITDA bene
Slide 18: 9M 2024 EBIT
FINE FOODS 9M 2024 FINANCIALS 18 RESULTS PRESENTATION 9M 2024 REPORTED EBIT (€M) +424.6% EBIT REVENUE % +5.1 €M in 9M 2024 ADJ EBIT 11.4 9M 2024 ADJ EBIT benefited from the 2.2 same items that affected the ADJ EBITDA performance 9M 2023 9M 2024 9M 2023 EBIT was affected by the Pharmatek goodwill imp
Slide 19: 9M 2024 Net Result
FINE FOODS 9M 2024 FINANCIALS 19 RESULTS PRESENTATION 9M 2024 REPORTED NET RESULT (€M) N/A Net Result REVENUE % Significant improvement in the Group Net 6.6 Result in 9M 2024 (1.8) 9M 2023 ADJ Net Result was net of the goodwill write down and positively impacted by the Parent Company’s asset securit
Slide 20: Robust Balance Sheet
FINE FOODS 9M 2024 FINANCIALS 20 RESULTS PRESENTATION Robust LEVERAGE RATIO* LEVERAGE RATIO* 1.69X 1.45X Balance Sheet Amortisation Buy Back NFP ∆ NFP Net Income & & 31/12/2023 NWC Others CAPEX 30/09/2024 Depreciation Dividends 3.0 Net Financial Position (NFP) 45.0 €M (+1.5 (43.6) 4.5 11.7 (45.0) €M
Slide 21: Guidelines for future growth
FINE FOODS 9M 2024 FINANCIALS 21 RESULTS PRESENTATION Guidelines for Despite the current international economic and geopolitical situation, and temporary shifts in some customers' inventory management, the target markets continue to future growth expand. Fine Foods is set on growing its market share
Slide 22: Shareholding Structure
FINE FOODS 9M 2024 22 RESULTS PRESENTATION SHAREHOLDING STRUCTURE
Slide 23: Shareholding structure
FINE FOODS 9M 2024 SHAREHOLDING 23 RESULTS PRESENTATION STRUCTURE Shareholding FINE FOODS SHARES N. OF SHARES (Million) % FLOATING (ON LISTED SHARES) structure ~54.8% LISTED SHARES 22.1 86% UNLISTED SHARES* 3.5 14% As of 14.11.2024 TOTAL EQUITY CAPITAL 25.6 100% 4.2% * Unlisted shares are Multiple V
Slide 24: Investor Information & Contacts
FINE FOODS 9M 2024 24 RESULTS PRESENTATION INVESTOR INFORMATION & CONTACTS
Slide 25: Investor Information
FINE FOODS 9M 2024 INVESTOR INFORMATION 25 RESULTS PRESENTATION AND CONTACTS Investor MARKET EURONEXT STAR MILAN Information ISIN CODE IT0005215329 TICKER FF BANCA AKROS S.p.A. Analyst: Andrea Todeschini E-mail: andrea.todeschini@bancaakros.it SPECIALIST Recommendation: Buy Target Price: € 12.50 Las
Slide 26: Why Fine Foods?
FINE FOODS 9M 2024 INVESTOR INFORMATION 26 RESULTS PRESENTATION AND CONTACTS Why Fine Foods? Reliability Performance Positioning • Holistic sustainability • Solid track record with • Unique presence in since foundation a 10-year revenue Nutra, Pharma and CAGR of 11% Cosmetic sectors • Advanced HR ma
Slide 27: Contacts
FINE FOODS 9M 2024 INVESTOR INFORMATION 27 RESULTS PRESENTATION AND CONTACTS Contacts Fine Foods & Pharmaceuticals N.T.M. S.p.A. Tel. +39 035 4821382 Investor Relations & Communication Advisor: Michaela M. Carboni Investor Relations: ir@finefoods.it Media Relations: media.relations@finefoods.it
Slide 28: Disclaimer
FINE FOODS 9M 2024 INVESTOR INFORMATION 28 RESULTS PRESENTATION AND CONTACTS Disclaimer This document has been prepared by Fine Foods & The information contained in this document, unless Pharmaceuticals N.T.M. S.p.A. for the sole purpose otherwise specified is only current as of the date of this des
Slide 29: Back Up ESG Details
FINE FOODS 9M 2024 29 RESULTS PRESENTATION BACK UP ESG DETAILS
Slide 30: Fine Foods' Group sustainability pillars
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 30 RESULTS PRESENTATION People Fine Foods’ Group Environment Ethics & sustainability Governance pillars Supply Sustainable Chain Products Land Development
Slide 31: ESG main initiatives and results
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 31 RESULTS PRESENTATION Social ESG Environment Governance main CIRCULAR ECONOMY • Programs for reduction of WE ATTRACT ~ 11,000 applications/year BOARD OF DIRECTORS • 4 Women out of 10 Directors initiatives environmental impact of waste • 4 Independent Direct
Slide 32: Ratings, ESG Commitment and Certifications
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 32 RESULTS PRESENTATION Ratings, RATINGS ESG Sedex Member Commitment and ESG COMMITMENT Certifications BENEFIT CORPORATION 231 Organizational, Since 2021 managerial and control New membership to the models to prevent network of companies on crimes Diversity a
Slide 33: People
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 33 RESULTS PRESENTATION People WE ATTRACT ~ 11.000 WOMEN ~ 47% of managers SAFETY AT WORK Management system for applications/year ~ 40% of Board health and safety We are committed members is internationally to creating an certified since 2014** environment ta
Slide 34: Corporate Governance
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 34 RESULTS PRESENTATION Corporate →4 Women out of 10 Directors Governance →4 Independent Directors out of 10 →4 Non-executive Directors out of 10 Our governance is structured around an ESG responsible approach. It allows us to pursue a sustainable growth whil
Slide 35: Sustainable products
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 35 RESULTS PRESENTATION OUR SERVICES Sustainable products Environmental Product carbon Product labelling footprint calculation eco-design Support and service to consultation support support develop products that provide environmental, social and economic bene
Slide 36: Relations with local communities
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 36 RESULTS PRESENTATION Relations SOCIAL RESPONSIBILITY TRADE ASSOCIATIONS with local communities ~500 students involved in meetings on sustainability and orientation issues 9 students accepted for internships and school-to-work projects MAIN COLLABORATIONS 5
Slide 37: Suppliers' ESG management
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 37 RESULTS PRESENTATION Suppliers’ ESG ENVIRONMENTAL AND SOCIAL ASSESSMENT OF OUR SUPPLIERS management 89% Value of purchases of raw materials and packaging from suppliers assessed by EcoVadis on ESG criteria 92% Value of purchases of raw materials and packag
Slide 38: Environment
FINE FOODS 9M 2024 BACK UP – ESG DETAILS 38 RESULTS PRESENTATION Environment We are committed to sustainably use our resources and reduce our environmental impact. CLIMATE WATER RESOURCES CIRCULAR ECONOMY ENVIRONMENT PROTECTION • -19% CO2 • Programs for • Programs for emissions intensity reduction o
Fine Foods & Pharmaceuticals N.t.m. — 9M 2024 Earnings Presentation on 6ix